Matching trials
1,853 results
- Reducing Bacteria That Cause Tooth Decay: Complete Statistical AnalysisIndependent statistical analysis of Reducing Bacteria That Cause Tooth Decay: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03062605).
- Reduction in the Occurrence of Center-Involved Diabetic Macular Edema: Complete Statistical AnalysisIndependent statistical analysis of Reduction in the Occurrence of Center-Involved Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00090519).
- REFLEXIONIndependent statistical analysis of Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00813709).
- Regadenoson Real Time Perfusion Imaging Trial-Optison: Complete Statistical AnalysisIndependent statistical analysis of Regadenoson Real Time Perfusion Imaging Trial-Optison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01489176).
- Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698): Complete Statistical AnalysisIndependent statistical analysis of Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RELATIVITY-047Independent statistical analysis of RELATIVITY-047, evaluating relatlimab plus nivolumab versus nivolumab alone in participants with advanced melanoma, including trial design, progression-free survival, statistical methodology, interpretation, and limitations.
- RELAX-AHF-2Independent statistical analysis of Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELAX-AHF-EUComplete statistical analysis of RELAX-AHF-EU, a randomized phase 3 trial evaluating serelaxin plus standard of care versus standard of care in patients with acute heart failure, including time-to-event, categorical, continuous, and longitudinal…
- RELAX-AHF-EUIndependent statistical analysis of Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELEASE MSS5Independent statistical analysis of Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- REMAP-CAPAn independent statistical analysis of REMAP-CAP, the randomized phase 3 multifactorial adaptive platform trial evaluating multiple treatment strategies in community-acquired pneumonia, influenza, and COVID-19.
- REMATCHIndependent statistical analysis of REMATCH (NCT00000607), a randomized phase 3 trial comparing left ventricular assist device with optimal medical therapy for congestive heart failure.
- REMDACTAIndependent statistical analysis of the REMDACTA phase 3 trial of remdesivir plus tocilizumab versus remdesivir plus placebo in hospitalized participants with severe COVID-19 pneumonia, including time-to-event, logistic regression, and categorical endpoint results.
- REMOVALIndependent statistical analysis of REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RENOIRIndependent statistical analysis of the phase 3 RENOIR trial evaluating RSVpreF in adults with lower respiratory tract illness, including trial design, endpoints, planned statistical methods, immunogenicity, safety, and interpretation.
- RESPIRE 1Independent statistical analysis of RESPIRE 1, a randomized phase 3 trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis, including time-to-exacerbation and exacerbation-rate analyses.
- RESPIRE 1Independent statistical analysis of Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RESTOREIndependent statistical analysis of A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24…
- RETAINIndependent statistical analysis of Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus:…
- ReTHINKIndependent statistical analysis of Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.: primary endpoint results, effect estimate with confidence interval, sample-size…
- RHINEIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RIFASHORTIndependent statistical analysis of the RIFASHORT phase 3 trial evaluating 1200mg and 1800mg rifampicin for pulmonary tuberculosis, including trial design, endpoints, planned statistical methods, and interpretation.
- RIVER-PCIComplete statistical analysis of RIVER-PCI, a randomized phase 3 trial of ranolazine versus placebo after PCI in patients with coronary artery disease and angina pectoris, including time-to-event endpoints, Cox modeling, hazard ratios,…
- RLSIndependent statistical analysis of Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ROCKET AFIndependent statistical analysis of ROCKET AF, the randomized phase 3 trial of rivaroxaban versus warfarin for prevention of stroke and non-CNS systemic embolism in patients with non-valvular atrial fibrillation.
- ROSEIndependent statistical analysis of A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RTOG 0617Independent statistical analysis of RTOG 0617, evaluating radiation therapy dose and cetuximab with chemotherapy in newly diagnosed unresectable stage III non-small cell lung cancer, with emphasis on survival, competing risks, safety, and…
- RTOG 0825Independent statistical analysis of RTOG 0825, a randomized phase 3 trial of temozolomide and radiation therapy with or without bevacizumab in patients with newly diagnosed glioblastoma.
- RUBATOIndependent statistical analysis of Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RxPONDERIndependent statistical analysis of the randomized phase 3 RxPONDER trial, including its invasive disease-free survival endpoint, Cox proportional-hazards analyses, menopausal-status interaction, post-hoc distant relapse-free survival results, safety, and statistical interpretation.
- S1216A detailed statistical analysis of S1216, a randomized phase 3 trial comparing LHRHa plus TAK-700 with LHRHa plus bicalutamide in metastatic prostate cancer, including overall survival, progression-free survival, Cox modeling, hazard ratios,…
- SADHART-CHFIndependent statistical analysis of Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SAILINGComplete statistical analysis of the SAILING phase 3 trial comparing GSK1349572 (dolutegravir) with raltegravir in antiretroviral-experienced, integrase inhibitor-naive adults with HIV infection, including its non-inferiority design, Cochran-Mantel-Haenszel analysis, risk difference, confidence interval,…
- SAMURAIComplete statistical analysis of the phase 3 SAMURAI trial of lasmiditan versus placebo for acute migraine, including trial design, binary endpoints, logistic regression, odds ratios, confidence intervals, p-values, safety, and interpretation.
- SANDPIPERIndependent statistical analysis of A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase…
- SAPPHIREA detailed statistical analysis of the SAPPHIRE phase 3 randomized trial of carotid artery stenting in patients with carotid artery disease, including its endpoints, design, planned time-to-event analysis, and statistical interpretation.
- SAPPHIREIndependent statistical analysis of Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SAXAPCOSIndependent statistical analysis of Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SCASTIndependent statistical analysis of SCAST, the Scandinavian Candesartan Acute Stroke Trial, including trial design, endpoints, planned statistical methods, and interpretation.
- SCD-HeFTAn independent statistical analysis of SCD-HeFT, a randomized phase 3 trial evaluating amiodarone and implantable defibrillators in patients with heart failure and related cardiovascular conditions.
- SCORPIOComplete statistical analysis of the SCORPIO phase 3 trial of mirabegron in patients with symptoms of overactive bladder, including endpoint definitions, ANCOVA methodology, efficacy results, multiplicity, missing-data handling, and safety.
- SCORPIO-HRComplete statistical analysis of the SCORPIO-HR phase 3 trial of S-217622 (ensitrelvir) versus placebo in non-hospitalized participants with SARS-CoV-2 infection, including trial design, time to sustained symptom resolution, restricted mean symptom duration,…
- SEAMLESSIndependent statistical analysis of A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SELECT-EARLYIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate: primary endpoint results, effect estimate…
- SELECTSUNRISEIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and…
- SEQUOIA-HCMIndependent statistical analysis of Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM: primary endpoint results, effect estimate with confidence interval, sample-size…
- SERAPHINIndependent statistical analysis of SERAPHIN, the randomized phase 3 trial of macitentan in symptomatic pulmonary arterial hypertension, including time-to-event endpoints, hazard ratios, confidence intervals, log-rank testing, and interpretation.
- SERENITY IIIndependent statistical analysis of Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04276883).